medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2013, Number 2

<< Back Next >>

Salud Mental 2013; 36 (2)

Endogenous opioids participation in the effect of Rosmarinus officinalis L. in the visceral, inflammatory and gout arthritis nociception in rodents

Martínez AL, González-Trujano ME, López-Muñoz FJ

Language: English
References: 34
Page: 141-147
PDF size: 297.5 Kb.


ABSTRACT

The aim of this study was to investigate the endogenous opioid participation in the antinociceptive effect of R. officinalis aerial parts in experimental models of visceral, inflammatory and gout arthritis nociception. Acid-acetic induced writhing and formalin tests as well as the pain-induced functional impairment model in the rat (PIFIR) assay were studied. Antinociceptive doses of R. officinalis via oral, alone and in presence of an opioid antagonist were evaluated in comparison to the reference analgesic drug tramadol (31.6 and 50mg/kg i.p., in mice and rats, respectively). The antinociceptive effect of R. officinalis at a 300mg/kg dosage was significantly reverted in presence of 1.0mg/ kg s.c. of naloxone in writhing and formalin tests. Concerning PIFIR model, significant antinociceptive response produced for 1000 and 3000mg/kg was not inhibited in presence of 1.0 or 3.16mg/kg, s.c. of naloxone. In the antinociceptive effect of tramadol, naloxone produced partial inhibition in all models tested. These results suggest that antinociceptive and anti-inflammatory activities of R. officinalis aerial parts involve endogenous opioids, but activation of these mediators depends on the experimental model and the physiological process of the induced nociception.


REFERENCES

  1. Herz A, Teschemacher H. Activities and sites of antinociceptive action of morphine-like analgesics. Adv Drug Res 1971;6:79-119.

  2. Yaksh TL, Rudy TA. Analgesia mediated by a direct spinal action of narcotics. Science 1976;192:1357-1358.

  3. Chen SR, Pan HL. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids. Brain Res 2006;1081:119-125.

  4. Ferreira SH, Nakamura M. Prostaglandin hyperalgesia: The peripheral analgesic activity of morphine, enkephalins and opioid antagonists. Prostaglandins 1979a;18:191-200.

  5. Stein C, Gramsch C, Herz A. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and β-endorphin. J Neurosci 1990;10:1292-1298.

  6. Al-Sereiti MR, Abu-Amer KM, Sen P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol 1999;37:124-130.

  7. Romo de Vivar A. Productos Naturales de la Flora Mexicana. México: Limusa; 1985.

  8. Martínez M. Las plantas medicinales de México. 6th Ed. Mexico City: Botas; 1989.

  9. Argueta VA. Atlas de las plantas medicinales tradicionales mexicanas. México: Instituto Indigenista; 1994.

  10. Hosseinzadeh H, Nourbakhsh M. Effect of Rosmarinus officinalis L. aerial parts extract on morphine withdrawal syndrome in mice. Phytother Res 2003;17:938-941.

  11. Capasso A, Picacente S, Pizza C, Sorrentino L. Flavonoids reduce morphine withdrawal in vitro. J Pharm Pharmacol 1998;50:561-564.

  12. Capasso A, Saturnino P, Simone FD, Aquino R. Flavonol glycosides from Aristeguietia discolor reduce morphine withdrawal in vitro. Phytother Res 2000;14:538-540.

  13. Rajendran NN, Thirugnanasambandam P, Viswanathan S, Parvathavarthini S et al. Antinociceptive pattern of flavone and its mechanism as tested by formalin assay. Indian J Exp Biol 2000;38:182-185.

  14. González-Trujano ME, Peña EI, Martínez AL, Guevara-Fefer P et al. Evaluation of the antinociceptive effect of Rosmarinus officinalis L. using three different experimental models in rodents. J Ethnopharmacol 2007;111:476-482.

  15. Ferrada M. Etnografía, un enfoque para la investigación de Weblogs en Biblioteconomía y documentación. Biblios [edición online]. 2006;7(23) [9 páginas]. Accesible en URL: http://eprints.rclis.org/7395/1/2005_ 19.pdf. Consultada el 11 de mayo de 2011.

  16. Collier HO, Dinneen LC, Johnson CA, Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother 1968;32:295-310.

  17. Mayring P. Qualitative Content Analysis. Forum Qual Soc Res [edición online]. 2000;1(2) [10 páginas]. Accesible en URL: http://www. qualitative-research.net/index.php/fqs/article/view/1089. Consultada el 6 de enero de 2011.

  18. López-Muñoz FJ, Salazar LA, Castañeda-Hernández G, Villarreal JE. A new model to assess analgesic activity: pain-induced functional impairment in the rat (PIFIR). Drug Dev Res 1993;28:169-175.

  19. Rowland M, Toser TN. Clinical Pharmacokinetics: concepts and applications. 2nd Ed. Philadelphia: Lea & Febiger; 1989.

  20. Koster R, Anderson M, De Beer EJ. Acetic acid analgesic screening. Fed Proc 1959;18:418-420.

  21. Abbott FV, Franklin KBJ, Westbrook RF. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 1995;60:91-102.

  22. Shibata M, Okhubo T, Takahashi H, Inoki R. Modified formalin test: Characteristics biphasic pain response. Pain 1989;38:346-352.

  23. Ferreira SH. Inflammatory pain, prostaglandin hyperalgesia and the development of peripheral analgesics. Trends Pharmacol Sci 1981;2:183-186.

  24. Jaffe JH, Martin WR. Opioid analgesics and antagonists. En: Gilman AG, Rall TW, Nies AS, Taylor P (eds.). Goodman and Gilman´s the pharmacological basis of therapeutics. 9th Ed. New York: MacMillan; 1990.

  25. Ferreira SH, Nakamura M. Prostaglandin hyperalgesia: a cAMP/Ca+2- dependent process. Prostaglandins 1979b;18:179-190.

  26. Stein C, Millan MJ, Shippenberg TS, Peter K et al. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 1989;248:1269-1275.

  27. Khoury GF, Chen ACN, Garland DE, Stein C. Intraarticular morphine, bupivacaine and morphine/bupivacaine for pain control after knee videoarthroscopy. Anesthesiology 1992;77:263-266.

  28. Hong Y, Abbott FV. Peripheral opioid modulation of pain and inflammation in the formalin test. Eur J Pharmacol 1995;277:21-28.

  29. Janson W, Stein C. Peripheral opioid analgesia. Curr Pharm Biotechnol 2003;4:270-274.

  30. Rodrigues ARA, Duarte IDG. The peripheral antinociceptive effect induced by morphine is associated with ATP-sensitive K+ channels. Br J Pharmacol 2000;129:110-114.

  31. Roane DS, Boyd NE. Reduction of food intake and morphine analgesia by central glybenclamide. Pharmacol Biochem Behav 1993;46:205-207.

  32. Stein C, Hassan AHS, Lehrberger K, Giefing J. Local analgesic effect of endogenous opioid peptides. Lancet 1993;342:321-324.

  33. Hara K, Minami K, Sata T. The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acid A, and N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Anesth Analg 2005;100:1400-1405.

  34. Koga A, Fujita T, Totoki T, Kumamoto E. Tramadol produces outward currents by activating mu-opioid receptors in adult rat substantia gelatinosa neurones. Br J Pharmacol 2005;145:602-607.




2020     |     www.medigraphic.com